Temozolomide (Mylan Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Temozolomide drug offered from Mylan Pharmaceuticals Inc.. This Alkylating Activity [MoA],Alkylating Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Mylan Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | temozolomide |
| SUBSTANCE NAME: | TEMOZOLOMIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Alkylating Activity [MoA],Alkylating Drug [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-06-29 |
| END MARKETING DATE: | 0000-00-00 |
Temozolomide HUMAN PRESCRIPTION DRUG Details:
| Item Description | Temozolomide from Mylan Pharmaceuticals Inc. |
| LABELER NAME: | Mylan Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5(mg/1) |
| START MARKETING DATE: | 2016-06-29 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0378-5260_a388a2cb-a70a-4299-93ac-eb59e32f4a49 |
| PRODUCT NDC: | 0378-5260 |
| APPLICATION NUMBER: | ANDA205227 |
Other TEMOZOLOMIDE Pharmaceutical Manufacturers / Labelers:
